[go: up one dir, main page]

BRPI0411841A - cis-2,4,5-triaryl imidazolines - Google Patents

cis-2,4,5-triaryl imidazolines

Info

Publication number
BRPI0411841A
BRPI0411841A BRPI0411841-3A BRPI0411841A BRPI0411841A BR PI0411841 A BRPI0411841 A BR PI0411841A BR PI0411841 A BRPI0411841 A BR PI0411841A BR PI0411841 A BRPI0411841 A BR PI0411841A
Authority
BR
Brazil
Prior art keywords
cis
triaryl
imidazolines
triaryl imidazolines
imidazolins
Prior art date
Application number
BRPI0411841-3A
Other languages
Portuguese (pt)
Inventor
Gregory Jay Haley
Norman Kong
Emily Aijun Liu
Klaus B Simonsen
Binh Thanh Vu
Stephen Evan Webber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0411841A publication Critical patent/BRPI0411841A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"CIS-2,4,5-TRIARIL-IMIDAZOLINAS". A presente invenção fornece compostos de acordo com a fórmula I tendo as designações aqui fornecidas, e sais e ésteres farmaceuticamente aceitáveis deste. Estes compostos inibem a interação de proteína de MDM2 com um peptídeo tipo p53 e têm atividade antiproliferativa."CIS-2,4,5-TRIARYL-IMIDAZOLINS". The present invention provides compounds according to formula I having the names given herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.

BRPI0411841-3A 2003-06-17 2004-06-08 cis-2,4,5-triaryl imidazolines BRPI0411841A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47935103P 2003-06-17 2003-06-17
PCT/EP2004/006176 WO2005003097A1 (en) 2003-06-17 2004-06-08 Cis-2,4,5-triaryl-imidazolines

Publications (1)

Publication Number Publication Date
BRPI0411841A true BRPI0411841A (en) 2006-08-08

Family

ID=33563793

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411841-3A BRPI0411841A (en) 2003-06-17 2004-06-08 cis-2,4,5-triaryl imidazolines

Country Status (13)

Country Link
EP (1) EP1638942A1 (en)
JP (1) JP2006527712A (en)
KR (1) KR100768021B1 (en)
CN (1) CN100465163C (en)
AR (1) AR044703A1 (en)
AU (1) AU2004254187A1 (en)
BR (1) BRPI0411841A (en)
CA (1) CA2528119A1 (en)
CL (1) CL2004001484A1 (en)
MX (1) MXPA05013279A (en)
RU (1) RU2319696C2 (en)
TW (1) TW200510387A (en)
WO (1) WO2005003097A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7579368B2 (en) * 2005-03-16 2009-08-25 Hoffman-La Roche Inc. Cis-imidazolines
ES2538714T3 (en) * 2005-12-01 2015-06-23 F. Hoffmann-La Roche Ag 2,4,5-Triphenyl-imidazoline derivatives as inhibitors of the interaction between p53 and MDM2 proteins for use as anti-cancer agents
US8114095B2 (en) * 2006-11-10 2012-02-14 Bausch & Lomb Incorporated Intraocular lens injection apparatus and method
MX2009006397A (en) 2006-12-14 2009-08-13 Daiichi Sankyo Co Ltd Imidazothiazole derivatives.
US7625895B2 (en) * 2007-04-12 2009-12-01 Hoffmann-Le Roche Inc. Diphenyl-dihydro-imidazopyridinones
EP2298778A4 (en) 2008-06-12 2011-10-05 Daiichi Sankyo Co Ltd IMIDAZOTHIAZOLE DERIVATE HAVING A CYCLIC STRUCTURE OF 4,7-DIAZASPIRO®2.5OCITANE
CN102356085A (en) 2009-01-16 2012-02-15 第一三共株式会社 Imidazothiazole derivative having proline ring structure
IT1396520B1 (en) 2009-12-10 2012-12-14 Nuovo Pignone Spa COUPLING FOR ROTOR BALANCING
US20140328893A1 (en) 2011-10-11 2014-11-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nutlin compounds for use in the treatment of pulmonary hypertension
JP2019522633A (en) 2016-05-20 2019-08-15 ジェネンテック， インコーポレイテッド PROTAC antibody conjugates and methods of use
EP3883925A4 (en) * 2018-11-20 2021-12-29 Sironax Ltd Cyclic ureas
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030158A1 (en) * 1989-11-22 1991-05-23 Nahed K. Ahmed Cancer treatments
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
DE10043456A1 (en) * 2000-09-04 2002-03-14 Merck Patent Gmbh Use of ectoin or ectoin derivatives to stabilize p53
RU2305095C2 (en) * 2001-12-18 2007-08-27 Ф.Хоффманн-Ля Рош Аг Cis-2,4,5-triphenylimidazolines and pharmaceutical composition based on thereof

Also Published As

Publication number Publication date
AU2004254187A1 (en) 2005-01-13
CN100465163C (en) 2009-03-04
CA2528119A1 (en) 2005-01-13
AR044703A1 (en) 2005-09-21
RU2006100730A (en) 2006-08-10
CN1809538A (en) 2006-07-26
KR20060021902A (en) 2006-03-08
RU2319696C2 (en) 2008-03-20
WO2005003097A1 (en) 2005-01-13
KR100768021B1 (en) 2007-10-18
MXPA05013279A (en) 2006-03-09
JP2006527712A (en) 2006-12-07
CL2004001484A1 (en) 2005-05-27
TW200510387A (en) 2005-03-16
EP1638942A1 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
BR0215157A (en) Cis-2,4,5-triphenyl imidazolines and their use in the treatment of tumors
BR0215156A (en) Cis-imidazolines as mdm 2 inhibitors
BRPI0411841A (en) cis-2,4,5-triaryl imidazolines
ATE155486T1 (en) CYCLIC PEPTIDES AND THEIR USE
LU91225I2 (en) Plenaxis
ZA200104396B (en) Compositions and methods for stimulating gastrointestinal motility.
NZ514453A (en) Novel sulfonamide compounds and uses thereof
DK1246639T3 (en) GLP-2 formulations
CY1107853T1 (en) APPLICABLE AMINOXIC USES FOR THE TREATMENT OF BIPHICAL DISORDERS
BR0014651A (en) Beta2-mediated cell adhesion inhibitors
AR024364A1 (en) A COSMETIC COMPOSITION FOR SLIMMING TO L-ARGININE BASE, AN ANALOG OF L-ARGININE, OR ONE OF ITS DERIVATIVES, WHICH IS ADMINISTERED BY VIATOPICA
CY1110446T1 (en) USE (G) -2-CYANO-3-HYDROXY-BUT-2-ENOCHIC ACID- (4'-TRIFFluoromethylphenyl) -amide for multiple sclerosis therapy
DE60137948D1 (en) TRIAZINONE AND ITS MEDICAL APPLICATION
BR0309188A (en) Pyrazole compounds as antiinflammatory and analgesic agents
NO20052907D0 (en) Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferative agents.
PT1180094E (en) POLYMERIC AMINO ACIDS CASTING LIKE PHARMACEUTICAL AGENTS
AR028823A1 (en) 8A AND 9A READING OF 15 MEMBERS OF CLASS 6-O-METHYL-ERYTHROMYCIN A, A PROCEDURE FOR THE PREPARATION AND A PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF BACTERIAL INFECTIONS IN HUMAN AND ANIMAL BEINGS
BR0207077A (en) Terbinafine malic acid addition salts
BR9807506A (en) Amide derivatives and medicinal compositions thereof
EA200200682A1 (en) NEW COMPOUNDS OF N-BENZYLPIPERASINE, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE399018T1 (en) USE OF S-Ä2,3-BISPALMITOYLOXY-(2RS)-PROPYLÜCYSTEINYL-GNNDESNISFKEK (MALP-2)
BR0213463A (en) Macrolide-containing pharmaceutical compositions
ATE46347T1 (en) IMMUNOSTIMULATING PEPTIDES.
BR0313076A (en) Amlodipine Organic Acid Salt
WO2004089962A3 (en) New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.